US biopharmaceutical company Cingulate has announced the receipt of a $3m grant from a private foundation to expedite the ...

KalVista Pharmaceuticals, Inc.’s KALV share price has dipped by 5.86%, which has investors questioning if this is right time to buy.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The India Nutritional Supplements Market, valued at USD 11.85 billion in 2023, is poised for significant growth, projected to reach an impressive USD 28.70 billion by 2032. This expansion is expected ...